Atherosclerotic Cardiovascular Disease

>

Latest News

Seonkyeong Yang, PhD I Credit: University of Florida
Anti-CGRP mAbs Are Not Linked to Increased CVD Risk in Adults with Migraine

January 15th 2025

Anti-CGRP monoclonal antibodies for migraine prevention were not linked to increased cardiovascular risk, per a Medicare study, addressing earlier safety concerns.

Polypill Therapy Cost-Effective for CVD Risk in Underserved Populations | Image Credit: Sardar Faizan/Unsplash
Polypill Therapy Cost-Effective for CVD Risk in Underserved Populations

January 8th 2025

Cardiology Year in Review: 2024
Cardiology Year in Review: 2024

December 26th 2024

Intensive Blood Pressure Regimen Lowers CVD Risk in People with T2D | Image Credit: American Heart Association
Intensive Blood Pressure Regimen Lowers CVD Risk in People with T2D

November 16th 2024

COVID-19 Pandemic Linked to 29% Higher Risk of Dyslipidemia, Study Finds| Image Credit: Albert Einstein College of Medicine
COVID-19 Pandemic Linked to 29% Higher Risk of Dyslipidemia, Study Finds

November 7th 2024

<123456
© 2025 MJH Life Sciences

All rights reserved.